Cenobamate for seizures in the ICU
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if a new seizure medicine called cenobamate can help control frequent or ongoing seizures in intensive care unit patients who are already on other seizure medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are having your brain waves monitored (EEG) in the hospital.
- You have frequent seizures (more than 1 per hour) or a seizure that lasts longer than 5 minutes, or heavy seizure activity in the last hour.
- Your doctor has decided you need an additional seizure medication on top of what you are already taking.
- You have not had a rash from any medication in the past.
- You are not taking medications that can change how your body absorbs medicines through the gut (like phenobarbital or pentobarbital).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called COBENFY (trospium chloride) can improve memory and brain wave activity in adults with epilepsy who are already scheduled for brain surgery with electrodes. It aims to see if enhancing a brain chemical called acetylcholine helps with memory and seizure focus.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This trial tests whether a new seizure medicine (cenobamate) helps people whose seizures are caused by an overactive immune system. You would stay on your current treatments and add cenobamate to see if it reduces seizures.
This study looks at how well cenobamate works when added to other seizure medications for adults with focal epilepsy. It uses real-world data from medical records to see how people respond to treatment.
This study looks at how cenobamate (a medication for seizures) affects healthcare use, like hospital visits or emergency room trips, in people with epilepsy whose seizures were not well-controlled by 2 to 5 other medicines. It is a real-world study, meaning it uses medical records to understand the impact.
This trial studies the safety of cenobamate for Japanese people who have partial onset seizures and have already finished a previous study of the same drug. It helps doctors learn more about long-term safety.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.